USPTO serial 79428498
MFOAMER
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAVACHE, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MFOAMER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lisa K. Shebar
Lisa K. Shebar Tarolli, Sundheim, Covell & Tummino LLP950 Main Avenue, Suite 710Cleveland, OH 44113United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Surgical apparatus and instruments; medical apparatus and instruments, namely, catheters, syringes sold empty; dental apparatus and instruments, namely, dental picks and dental mirrors; veterinary instruments and apparatus, namely catheters for veterinary use; artificial limbs, eyes and teeth; orthopedic articles namely, orthopedic braces; thread, surgical; therapeutic and assistive devices adapted for disabled people, namely, walking frames for disabled people; massage apparatus; apparatus, devices and articles for infant care, namely, baby bottles and incubators for babies; sexual activity apparatus, devices and articles, namely, condoms and sex toys; disposable interchangeable cassettes, sold empty, for connection to medical apparatus for use in sclerotherapy, specifically for producing therapeutic foam; medical apparatus and instruments, namely, medical syringes sold empty, in particular for use in sclerotherapy of veins, including the performance of treatments in the fields of phlebology, proctology and angiology; surgical apparatus and instruments, in particular for use in sclerotherapy of veins, including the performance of treatments in the fields of phlebology, proctology and angiology; medical devices for the conversion of pharmaceutical preparations, namely, medical apparatus for introducing pharmaceutical preparations into the human body; medical devices for the production of medical foam, in particular for the production of microfoam for sclerotherapy; medical devices for introducing pharmaceutical preparations into the human body, in particular for introducing microfoam; medical apparatus and instruments for the treatment of varicose veins, namely, medical lasers for the treatment of varicose veins; apparatus and instruments for mixing substances for medical purposes, namely, medical apparatus and instruments for custom mixing of microfoam for treatment of varicose veins; apparatus and instruments for transforming substances for medical purposes, namely, medical apparatus and instruments for custom preparation of foam-based sclerotherapy treatments; medical and surgical apparatus and instruments for the intravenous administration of foam; connecting mechanisms for syringes for medical purposes, namely, syringe guns for medical use; medical and surgical apparatus and instruments for monitoring the position and effect of foam in the human body | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 3, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 22, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 22, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 22, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 22, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 22, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 9, 2026 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 8, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 8, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 8, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 16, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 16, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 16, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 3, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 16, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 16, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 6, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 5, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 29, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 28, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 28, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 24, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |